A review on leukotrienes and their receptors with reference to asthma - PubMed (original) (raw)
Review
A review on leukotrienes and their receptors with reference to asthma
Rakesh Kumar Singh et al. J Asthma. 2013 Nov.
Abstract
Objective and methods: Leukotrienes (LTs) including cysteinyl leukotrienes (CysLTs) and LTB4 are the most potent inflammatory lipid mediators and play a central role in the pathophysiology of asthma and other inflammatory diseases. These biological molecules mediate a plethora of contractile and inflammatory responses through specific interaction with distinct G protein-coupled receptors (GPCRs). The main objective of this review is to present an overview of the biological effects of CysLTs and their receptors, along with the current knowledge of mechanisms and role of LTs in the pathogenesis of asthma.
Results: CysLTs including LTC4, LTD4 and LTE4 are ligands for CysLT1 and CysLT2 receptors, and LTB4 is the agonist for BLT1 and BLT2 receptors. The role of CysLT1 receptor is well established, and most of the pathophysiological effects of CysLTs in asthma are mediated by CysLT1 receptor. Several CysLT1 antagonists have been developed to date and are currently in clinical practice. Most common among them are classical CysLT1 receptor antagonists such as montelukast, zafirlukast, pranlukast, pobilukast, iralukast, cinalukast and MK571. The pharmacological role of CysLT2 receptor, however, is less defined and there is no specific antagonist available so far. The recent demonstration that mice lacking both known CysLT receptors exhibit full/augmented response to CysLT points to the existence of additional subtypes of CysLT receptors. LTB4, on the other hand, is another potent inflammatory leukotriene, which acts as a strong chemoattractant for neutrophils, but weaker for eosinophils. LTB4 is known to play an important role in the development of airway hyper-responsiveness in severe asthma. However there is no LTB4 antagonist available in clinic to date.
Conclusion: This review gives a recent update on the LTs including their biosynthesis, biological effects and the role of anti-LTs in the treatment of asthma. It also discusses about the possible existence of additional subtypes of CysLT receptors.
Similar articles
- The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN, Mohammed LA. Sharma JN, et al. Inflammopharmacology. 2006 Mar;14(1-2):10-6. doi: 10.1007/s10787-006-1496-6. Inflammopharmacology. 2006. PMID: 16835707 Review. - Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW. Jonsson EW. Acta Physiol Scand Suppl. 1998 Mar;641:1-55. Acta Physiol Scand Suppl. 1998. PMID: 9597121 Review. - Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK, Gupta S, Dastidar S, Ray A. Singh RK, et al. Pharmacology. 2010;85(6):336-49. doi: 10.1159/000312669. Epub 2010 Jun 2. Pharmacology. 2010. PMID: 20516735 Review. - Leukotriene modifiers for asthma treatment.
Montuschi P, Peters-Golden ML. Montuschi P, et al. Clin Exp Allergy. 2010 Dec;40(12):1732-41. doi: 10.1111/j.1365-2222.2010.03630.x. Clin Exp Allergy. 2010. PMID: 21059119 Review. - Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
Leff AR. Leff AR. Annu Rev Med. 2001;52:1-14. doi: 10.1146/annurev.med.52.1.1. Annu Rev Med. 2001. PMID: 11160764 Review.
Cited by
- Aspirin Hypersensitivity in Patients with Coronary Artery Disease: An Updated Review and Practical Recommendations.
Cappannoli L, Colantuono S, Animati FM, Fracassi F, Galli M, Aurigemma C, Romagnoli E, Montone RA, Lunardi M, Paraggio L, Ierardi C, Baglivo I, Caruso C, Trani C, Burzotta F. Cappannoli L, et al. Biomolecules. 2024 Oct 19;14(10):1329. doi: 10.3390/biom14101329. Biomolecules. 2024. PMID: 39456262 Free PMC article. Review. - Leukotriene signaling in neurodegeneration: implications for treatment strategies.
Sharma V, Sharma P, Singh TG. Sharma V, et al. Inflammopharmacology. 2024 Dec;32(6):3571-3584. doi: 10.1007/s10787-024-01557-1. Epub 2024 Aug 21. Inflammopharmacology. 2024. PMID: 39167313 Review. - Parallel Synthesis of Piperazine Tethered Thiazole Compounds with Antiplasmodial Activity.
Rayala R, Chaudhari P, Bunnell A, Roberts B, Chakrabarti D, Nefzi A. Rayala R, et al. Int J Mol Sci. 2023 Dec 12;24(24):17414. doi: 10.3390/ijms242417414. Int J Mol Sci. 2023. PMID: 38139243 Free PMC article. - Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk.
Mirra D, Esposito R, Spaziano G, Rafaniello C, Iovino P, Cione E, Gallelli L, D'Agostino B. Mirra D, et al. J Clin Med. 2023 Apr 8;12(8):2775. doi: 10.3390/jcm12082775. J Clin Med. 2023. PMID: 37109111 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical